News

Perrigo (PRGO) reported $1.04 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 3.5%. EPS of $0.60 for the same period compares to $0.29 a year ago.

The

Teva Pharmaceutical Industries Ltd. (TEVA) reported $3.89 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 1.9%. EPS of $0.52 for the same period

For the quarter ended March 2025, Immunocore Holdings PLC Sponsored ADR (IMCR) reported revenue of $93.88 million, up 33.2% over the same period last year. EPS came in at $0.10, compared to -$0.49

For the quarter ended March 2025, EyePoint Pharmaceuticals (EYPT) reported revenue of $24.45 million, up 109.4% over the same period last year. EPS came in at -$0.65, compared to -$0.55 in the

IPG Photonics (IPGP) reported $227.79 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 9.6%. EPS of $0.31 for the same period compares to $0.52 a year

For the quarter ended March 2025, Acushnet (GOLF) reported revenue of $703.37 million, down 0.6% over the same period last year. EPS came in at $1.62, compared to $1.43 in the year-ago quarter.

The

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side)

From a technical perspective, CRA International (CRAI) is looking like an interesting pick, as it just reached a key level of support. CRAI recently overtook the 50-day moving average, and this

• Shares of Eli Lilly and Company LLY slid 5.6% on the session’s health care slump.
• Shares of Newmont Corporation NEM, the world's largest gold miner, jumped 3%, adding to yesterday's gains, as the

Wall Street closed lower on Tuesday, pulled down by health care, tech and discretionary stocks. Investor mood was grim on the White House’s continued see-sawing on global trade deals, and economic

Greystone Housing Impact Investors (GHI) came out with quarterly earnings of $0.31 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.42 per share a

GCM Grosvenor Inc. (GCMG) came out with quarterly earnings of $0.18 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.14 per share a year ago. These

BGC Group (BGC) came out with quarterly earnings of $0.29 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.25 per share a year ago. These figures are adjusted

Flex (FLEX) came out with quarterly earnings of $0.73 per share, beating the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.57 per share a year ago. These figures are

B&G Foods (BGS) came out with quarterly earnings of $0.04 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.18 per share a year ago. These figures

Omnicell, Inc. OMCL reported first-quarter 2025 adjusted earnings per share (EPS) of 26 cents compared with 3 cents in the year-ago period. The metric beat the Zacks Consensus Estimate by 62.5%.